CORDIS
EU research results

CORDIS

English EN

Validation of an industrial process to manufacture isosorbide bis(methyl carbonate) at pilot level

Project information

Grant agreement ID: 790440

Status

Ongoing project

  • Start date

    1 June 2018

  • End date

    31 May 2021

Funded under:

H2020-EU.3.2.6.1.

  • Overall budget:

    € 3 520 842,70

  • EU contribution

    € 2 814 876

Coordinated by:

FUNDACION TECNALIA RESEARCH & INNOVATION

Spain

Objective

The use of isosorbide (IS), a still a low market volume bio-based chemical but with a high Cumulative Annual Growing Rate of 10.9%, in the manufacturing of intermediate building blocks and high volume polymers, such as polycarbonates, has some drawbacks that could be overcome by using isosorbide bis(methyl carbonate) (IBMC), a barely explored IS secondary building block which is proposed to enhance IS value chain. VIPRISCAR main objectives are: 1) To validate at pilot scale in an industrially relevant environment (TRL 5) a sustainable IBMC production process from IS; 2) To show a proof of principle for the added value IBMC brings to the market by demonstrating the usefulness of polymers derived thereof in three high-volume market sectors: industrial coatings, hot-melt adhesives, and biomedicine (antithrombotic-antimicrobial catheters).
Results expected are: 1) A validated highly-efficient IBMC production process (TRL 5) able to be up-scaled and produce, under suitable market conditions, IBMC at a similar price to that of current oil-based monomers used in polycarbonates and polyurethanes; 2) at least 1 IBMC-derived coating for automotive and furniture; 3) at least 1 IBMC-derived hot-melt adhesive; 4) 1 antithrombotic-antimicrobial IBMC-derived catheter. Exploitation encompasses patent licensing, collaborative research for further development to high TRLs and direct production-commercialization (industrial partners).
The 3-years project is divided in 4 phases consisting of 8 WPs: 1) IBMC manufacturing process improvement to move from the current TRL of 3 (TEC granted patent) to 4 (WP2); 2) IBMC up-scaling to TRL 5 (WP3); 3) Proof of principle of IBMC applications (WP4-Coatings, WP5-Adhesives, WP6-Catheters); 4) Horizontal issues: Management (WP1); techno-economic analysis, LCA, REACH, health-safety, barriers and standards (WP7); market analysis, business models-financial impacts, IPR and exploitation, risk management, communication and dissemination strategy (WP8).

Coordinator

FUNDACION TECNALIA RESEARCH & INNOVATION

Address

Parque Cientifico Y Tecnologico De Bizkaia, Astondo Bidea, Edificio 700
48160 Derio Bizkaia

Spain

Activity type

Research Organisations

EU Contribution

€ 1 053 843

Participants (8)

JOWAT SE

Germany

CIKAUTXO S COOP

Spain

B4PLASTICS

Belgium

EU Contribution

€ 375 492

AEP POLYMERS SRL

Italy

EU Contribution

€ 221 940

VERTECH GROUP

France

EU Contribution

€ 406 000

EXERGY LTD

United Kingdom

EU Contribution

€ 277 576

FUNDACION GAIKER

Spain

EU Contribution

€ 226 310

ACONDICIONAMIENTO TARRASENSE ASSOCIACION

Spain

EU Contribution

€ 253 715

Project information

Grant agreement ID: 790440

Status

Ongoing project

  • Start date

    1 June 2018

  • End date

    31 May 2021

Funded under:

H2020-EU.3.2.6.1.

  • Overall budget:

    € 3 520 842,70

  • EU contribution

    € 2 814 876

Coordinated by:

FUNDACION TECNALIA RESEARCH & INNOVATION

Spain